A patient-like swine model of gastrointestinal fibrotic strictures for advancing therapeutics
Abstract Gastrointestinal (GI) strictures are difficult to treat in a variety of disease processes. Currently, there are no Food and Drug Administration (FDA) approved drugs for fibrosis in the GI tract. One of the limitations to developing anti-fibrotic drugs has been the lack of a reproducible, re...
Guardado en:
Autores principales: | Ling Li, Mohamad I. Itani, Kevan J. Salimian, Yue Li, Olaya Brewer Gutierrez, Haijie Hu, George Fayad, Jean A. Donet, Min Kyung Joo, Laura M. Ensign, Vivek Kumbhari, Florin M. Selaru |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0036aedcaedd4c609bd0bb02b3498583 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Comparison of EUS and ERCP-guided tissue sampling in suspected biliary stricture.
por: Hye Gyo Chung, et al.
Publicado: (2021) -
Transitional changes in gastrointestinal transit and rectal sensitivity from active to recovery of inflammation in a rodent model of colitis
por: Yan Chen, et al.
Publicado: (2021) -
Spontaneous Perforation of a Peptic Esophageal Stricture
por: Yankov G., et al.
Publicado: (2020) -
Tissue sampling for biliary strictures using novel elbow biopsy forceps
por: Huahui Zhang, et al.
Publicado: (2021) -
Pediatric Urethral Strictures and Management Strategies; An Evolving and Learning Experience
por: Mir Fahiem-ul-Hassan, et al.
Publicado: (2021)